CSIMarket Company Name, Ticker, Customers, else..


Harvard Bioscience Inc   (NASDAQ: HBIO)
Other Ticker:  
 

Harvard Bioscience Inc

HBIO's Fundamental analysis



Harvard Bioscience Inc 's sales fell by -9.36 % in IV. Quarter 2024 from the same quarter a year ago.

Laboratory Analytical Instruments industry recorded growth of revenues by 3.27 %

Harvard Bioscience Inc realized net income compared to net loss a year ago in IV. Quarter 2024

• More on HBIO's Growth


Harvard Bioscience Inc
realized a net loss in trailing twelve months.

Harvard Bioscience Inc realized cash reduction of $ -0 per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
10.68
PE TTM    
Company's Price to Sales ratio is at 0.31.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.44.


• More on HBIO's Valuation
 
 Total Debt (Millions $) 37
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 225,399
 Net Income/Employee (TTM) $ -29,820
 Receivable Turnover (TTM) 6.76
 Tangible Book Value (Per Share $) -0.09

Harvard Bioscience Inc
realized net loss in trailing twelve months.

Harvard Bioscience Inc realized cash outflow of $ -0per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
10.68
PE TTM    
Company's Price to Sales ratio is at 0.31.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.44.

Harvard Bioscience Inc Price to Book Ratio is at 0.45 lower than Industry Avg. of 246.24. and higher than S&P 500 Avg. of 0.01

• More on HBIO's Valuation

•  Market Capitalization (Millions $) 29
•  Shares Outstanding (Millions) 44
•  Employees 416
•  Revenues (TTM) (Millions $) 94
•  Net Income (TTM) (Millions $) -12
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -3
•  Total Debt (Millions $) 37
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 225,399
•  Net Income/Employee(TTM) $ -29,820
•  Receivable Turnover Ratio (TTM) 6.76
•  Tangible Book Value (Per Share $) -0.09

•  Market Capitalization (Millions $) 29
•  Shares Outstanding (Millions) 44
•  Employees 416
•  Revenues (TTM) (Millions $) 94
•  Net Income (TTM) (Millions $) -12
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -3


    HBIO's Profitability Comparisons
Harvard Bioscience Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 0.04 %.

Harvard Bioscience Inc net profit margin of 0.07 % is currently ranking no. 9 in Laboratory Analytical Instruments industry, ranking no. 162 in Healthcare sector and number 1918 in S&P 500.





  Ratio
•   Capital Ratio (MRQ) 0.88
•  Total Debt to Equity (MRQ) 0.58
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.73
•  Inventory Turnover Ratio (TTM) 1.58



Harvard Bioscience Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 0.04 %.

Harvard Bioscience Inc net profit margin of 0.07 % is currently ranking no. 9 in Laboratory Analytical Instruments industry, ranking no. 162 in Healthcare sector and number 1918 in S&P 500.

• More on HBIO's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com